ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation

Liver hepatocellular carcinoma (LIHC) is one of the main cancers worldwide and has high morbidity and mortality rates. Although previous studies have shown that ANXA10 is expressed at low levels in LIHC tumor tissues, the biological function of ANXA10 in LIHC is still unclear. Therefore, we utilized...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chaohua, Peng, Linglong, Gu, Haitao, Wang, Jijian, Wang, Yaxu, Xu, Zhiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884230/
https://www.ncbi.nlm.nih.gov/pubmed/36709331
http://dx.doi.org/10.1038/s41598-023-28527-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884230/
https://www.ncbi.nlm.nih.gov/pubmed/36709331
http://dx.doi.org/10.1038/s41598-023-28527-x

Ejemplares similares